Latest Breaking News On - Navidea manocept - Page 3 : comparemela.com

Navidea Biopharma (NAVB) Announces Board Changes

Navidea Biopharma (NAVB) Announces Board Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDanaj mossDana mossTheodore gerbickAmit bhallaNavidea manoceptJason myersJohnk scott jrTechnology expertiseSecurities exchangeCompany board of directorsMantech international corporationSchool scholarshipCompany boardGenapsys incHealth inc

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesAmit bhallaJohnk scott jrDana mossDanaj mossJason myersNavidea manoceptTheodore gerbickMantech international corporationUnited air force academyHealth incGenapsys incSecurities exchangePartner at cooleyLeadership council on legal diversityUniversity of texas at austin

Navidea Biopharmaceuticals, Inc Rejects Unsolicited Offer To Acquire Certain Assets

Navidea Biopharmaceuticals, Inc Rejects Unsolicited Offer To Acquire Certain Assets
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNavidea manoceptTheodore gerbickJosh wilsonCompany fixProphase labCardinal healthCompany board of directorsNavidea biopharmaceuticals incSecurities exchangeExecutive consultantsProphase labsSecurities actSecurities exchange actAnnual reportNavidea biopharmaceuticals

Navidea Biopharmaceuticals, Inc Receives $7 5 Million Cash From Cardinal Health In Lieu Of Contingent Milestone Payment

Continuing the Company s Fix, Fund, Propel approach, the cash payment from Cardinal Health aligns strategic goals while solidifying immediate capita

United statesTheodore gerbickNavidea manoceptJason myersCompany phase iibCardinal healthCardinal health incNavidea biopharmaceuticals incSecurities exchangeNews globalNavidea biopharmaceuticalsAsset purchase agreementMilestone paymentKeystone capital partnersExecutive consultantsKeystone partners

Navidea Biopharmaceuticals, Inc Receives $7 5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment

Continuing the Company’s Fix, Fund, Propel approach, the cash payment from Cardinal Health aligns strategic goals while solidifying immediate capital for funding Phase IIb and Phase III. | June 16, 2023

United statesNavidea manoceptJason myersNavidea biopharmaceuticals incCardinal healthCardinal health incSecurities exchangeCompany phase iibNavidea biopharmaceuticalsAsset purchase agreementMilestone paymentKeystone capital partnersExecutive consultantsKeystone partnersSecurities actSecurities exchange act